Troxerutin 7085-55-4

95% up by HPLC

Inquire now

Product categories

New Products

Product Details

Product Information

Product name	Troxerutin
CAS No.	7085-55-4
Molecular Formula	C33H42O19
Molecular Weight	742.685
Quality Standard	95% up
Appearance	Yellowish-green, crystalline powder

COA

ANALYSIS	SPECIFICATION	RESULTS
Appearance	Yellowish-green, crystalline powder	Yellowish-green, crystalline powder
Identification	The infrared absorption pattern should be consistent with reference product	Conforms
Identification	The principal peak in the chromatogram obtained with the test solution is similar to the chromatogram obtained with the reference solution (a)	Conforms
Related substance	Purity of main peak ≥ 80.0%	89.5%
	Peak of single maximum component ≤ 10.0%	2.7%
	Other single component peak ≤ 5.0%	2.1%
Ethylene oxide	≤ 1ppm	Not detected
Methanol	≤ 3000ppm	410ppm
Loss on drying	≤5.0%	0.68%
Sulphated ash	≤0.4%	0.07%
Assay	95.0% - 105.0%	100.8%
Microbial Limit	TAMC≤1000cfu/g	45cfu/g
	TYMC≤100cfu/g	<10cfu/g
	Escherichia coli: Not detected in 1g	Not detected
Conclusion	The sample complies with the Ph.Eur.11.2.

Usage

Troxerutin, also known as rutin derivative or venoruton, is a bioflavonoid compound derived from natural sources such as the Japanese pagoda tree, sophora japonica, and other plants. It is a yellowish-white crystalline powder that is highly soluble in water.

Pharmacological Effects

1. Anti-inflammatory Properties: Troxerutin has been shown to reduce the production of inflammatory

2. Antioxidant Properties: It acts as a powerful antioxidant by neutralizing free radicals, thus protecting cells and tissues from oxidative stress and damage.

3. Anti-cancer Properties: Troxerutin has demonstrated anti-cancer activity by inhibiting the growth and spread of cancer cells, and protecting healthy cells from damage caused by cancer treatments like chemotherapy and radiation therapy.

4. Vascular Effects: It helps to improve blood flow, reduce the risk of blood clots, and exhibits anti-thrombotic properties. Troxerutin also has a weak vasoconstrictive effect, reducing capillary permeability and fragility, thereby preventing edema caused by increased vascular permeability.